First US drug priced at more than $1 million may be on the horizon – CNBC
Investor’s Business Daily |
First US drug priced at more than $1 million may be on the horizon
CNBC New gene therapies that aim to cure hemophilia, a disease affecting the blood’s ability to clot, may carry prices of $1.5 million or more, analysts at Leerink wrote … Hemophilia Gene TherapiesInvestor’s Business Daily |
CBC.ca |
More than 400 people register to help Alberta man find stem cell donor
CBC.ca Nguyen’s family organized Sunday’s event to raise awareness of the lack of stem cell donors for ethnic minorities, particularly for people of Asian descent. His sister Susan Nguyen said they never expected more than 400 people would register as donors … Huge turnout at drive for diverse stem–cell donors gives hope to family of Bille NguyenToronto Star |
Genetic Engineering & Biotechnology News |
25 Up and Coming Gene Therapies
Genetic Engineering & Biotechnology News Additional figures furnished to GEN by Informa show the extent of gene–therapy development: Informa Pharma Intelligence’s Trialtrove database records 729 gene therapies as having been developed, of which nearly two-thirds (461) were preclinical. Those … |
Endpoints News |
Why Hemophilia Patients Could Pay $1.5 Million For Gene Therapy
Investor’s Business Daily Leerink analyst Joseph Schwartz boosted his projections for hemophilia gene therapies to $1.5 million from earlier assumptions for $350,000-$500,000 per patient. Some treatments could go as high as $2 million per patient on a gross basis, he said … US’s first drug priced at more than $1 million may be on the horizonCNBC Is biopharma’s first $1.5M therapy now in Phase III?Endpoints News |